Yvette Silvina Groszmann, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 7 | 2024 | 870 | 1.570 |
Why?
|
| Myometrium | 2 | 2023 | 174 | 0.790 |
Why?
|
| Abortion, Incomplete | 1 | 2018 | 14 | 0.640 |
Why?
|
| Pelvis | 3 | 2023 | 732 | 0.630 |
Why?
|
| Dilatation and Curettage | 1 | 2018 | 52 | 0.630 |
Why?
|
| Placenta, Retained | 1 | 2018 | 22 | 0.630 |
Why?
|
| Ultrasonography, Doppler | 3 | 2018 | 462 | 0.600 |
Why?
|
| Ultrasonography | 6 | 2024 | 5972 | 0.520 |
Why?
|
| Ovarian Diseases | 1 | 2014 | 137 | 0.430 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 940 | 0.370 |
Why?
|
| Infertility, Female | 1 | 2016 | 760 | 0.340 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 940 | 0.270 |
Why?
|
| Pelvic Pain | 1 | 2023 | 298 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.180 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 396 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2947 | 0.180 |
Why?
|
| Journal Impact Factor | 1 | 2020 | 153 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2014 | 1755 | 0.130 |
Why?
|
| Bibliometrics | 1 | 2020 | 352 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 637 | 0.120 |
Why?
|
| Aneuploidy | 2 | 2014 | 551 | 0.110 |
Why?
|
| Genital Diseases, Female | 1 | 2015 | 192 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2013 | 231 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2014 | 731 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2015 | 504 | 0.090 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 907 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1496 | 0.090 |
Why?
|
| Pregnancy | 5 | 2023 | 29874 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12974 | 0.080 |
Why?
|
| Female | 14 | 2024 | 392644 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2013 | 636 | 0.080 |
Why?
|
| Fetus | 1 | 2014 | 1863 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1186 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 14666 | 0.070 |
Why?
|
| Down Syndrome | 1 | 2014 | 901 | 0.070 |
Why?
|
| Crown-Rump Length | 2 | 2014 | 32 | 0.060 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2014 | 59 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 1420 | 0.060 |
Why?
|
| Humans | 14 | 2024 | 761504 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1801 | 0.050 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 463 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20098 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 4876 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 3123 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2018 | 80636 | 0.030 |
Why?
|
| Adult | 4 | 2014 | 221177 | 0.030 |
Why?
|
| Nose | 1 | 2014 | 521 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3530 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36426 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72334 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 88319 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 220895 | 0.000 |
Why?
|